CRISPR Technology Market 2022 Analysis By Size, Share, Growth, Trends up to 2026
Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc.
02-07-2022
Health & Medicine
Press release from: The Business research company
CRISPR Technology Market
The global CRISPR technology market size is expected to grow from $1064.91 million in 2021 to $1327.27 million in 2022 at a compound annual growth rate (CAGR) of 24.6%. The growth in the CRISPR market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The CRISPR technology market is expected to reach $3112.26 million in 2026 at a CAGR of 23.7%.
The CRISPR technology market consists of sales of CRISPR technology products and services which is a gene-editing technology that allows researchers to alter DNA sequences and modify gene function. CRISPR is a group of DNA sequences present in the genomes of bacteria and archaea, which are prokaryotic species. These sequences are obtained from bacteriophage DNA pieces that infected the prokaryote before.
Some key CRISPR technology market are Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc., Integrated DNA Technologies Inc. (Danaher), Origene Technologies Inc., Transposagenbio Biopharmaceuticals (Hera Biolabs), Intellia Therapeutics Inc. and GeneCopoeia Inc.
openpr.com |
